Quarterly report pursuant to Section 13 or 15(d)

Share-Based Compensation (Tables)

v3.24.3
Share-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Restricted Share Activity, Excluding Company's Employee Stock Purchase Plan
Number of
shares
Weighted
average
grant
date fair
value
Unvested at December 31, 2023 529,862  $ 11.42 
Granted 215,481  7.51 
Vested (85,648) 17.88 
Vested shares forgone to satisfy minimum statutory withholding (53,083) 17.88 
Forfeitures (14,750) 11.61 
Unvested at September 30, 2024 591,862  $ 8.48 
Three Months Ended September 30, Nine Months Ended September 30,
2024 2023 2024 2023
Weighted average grant date fair value of awards granted $ 6.90  $ 10.68  $ 7.51  $ 9.25 
Total fair value of shares vested $ 2,636  $ 79,944  $ 750,298  $ 649,612 
Total fair value of shares forgone to satisfy minimum statutory withholding $ 814  $ 34,371  $ 465,020  $ 364,758 
Schedule of Performance-Based Restricted Stock Units
Number of
shares
Weighted
average
grant
date fair
value
Unvested at December 31, 2023 112,776  $ 10.49 
Granted 117,582  5.69 
Performance adjustment upon vesting (17,690) 8.58 
Vested (13,022) 8.58 
Vested shares forgone to satisfy minimum statutory withholding (10,425) 8.58 
Unvested at September 30, 2024 189,221  $ 7.92 
Nine Months Ended September 30,
2024 2023
Weighted average grant date fair value of awards granted $ 5.69  $ 11.05 
Total fair value of shares vested $ 83,862  $ — 
Total fair value of shares forgone to satisfy minimum statutory withholding $ 67,137  $ — 
Schedule of Share-based Payment Arrangement, Option, Activity
2014 Plan (Options) Number
of Authorized
Shares
Weighted-
Average Exercise
Price
Weighted-
Average
Remaining
Contractual Term (in Years)
Aggregate
Intrinsic Value
Outstanding at December 31, 2023 657,346  $ 6.69  4.16 $ 2,983,514 
Exercised (35,487) 3.62  312,195 
Exercised shares forgone to satisfy minimum statutory withholding (14,654) 2.69 
Shares tendered for cashless exercise (43,193) 3.78 
Forfeitures and expirations (26,500) 11.49 
Outstanding at September 30, 2024 537,512  $ 6.98  3.83 $ 1,017,157 
Exercisable at September 30, 2024 537,512  $ 6.98  3.83 $ 1,017,157 
2021 Plan (Options) Number
of Authorized
Shares
Weighted-
Average Exercise
Price
Weighted-
Average
Remaining
Contractual Term (in Years)
Aggregate
Intrinsic Value
Outstanding at December 31, 2023 1,051,673  $ 11.05  8.79 $ 1,207,118 
Granted 866,147  6.80 
Forfeitures and expirations (89,965) 13.14 
Outstanding at September 30, 2024 (a) 1,827,855  $ 8.93  8.78 $ 256,759 
Exercisable at September 30, 2024 (a) 560,647  $ 12.01  7.71 $ — 
(a) Aggregate Intrinsic Value - no exercisable options were in-the-money as of September 30, 2024.
Schedule of Share-based Compensation Expense Based on Fair Value of Options
The following is the average fair value per share estimated on the date of grant and the assumptions used for options granted:
Three Months Ended September 30, Nine Months Ended September 30,
Stock Options: 2024 2023 2024 2023
Expected volatility
—%
53%
46% to 51%
53%
Risk free interest rate
—%
4.43% to 4.45%
4.25% to 4.60%
3.71% to 4.45%
Expected lives at date of grant (in years) 0.00 4.04 4.08 3.98
Weighted average fair value of options granted $— $4.90 $2.95 $4.07
Total intrinsic value of options exercised $ —  $ 1,646,254  $ 312,195  $ 3,067,467